The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Withaferin A Strongly Elicits IκB Kinase β Hyperphosphorylation Concomitant with Potent Inhibition of Its Kinase Activity
Open accessAbstract
The transcription factor NFkappaB plays a critical role in normal and pathophysiological immune responses. Therefore, NFkappaB and the signaling pathways that regulate its activation have become a major focus of drug development programs. Withania somnifera (WS) is a medicinal plant that is widely used in Palestine for the treatment of various inflammatory disorders. In this study we show that the leave extract of WS, as well as its major constituent withaferin A (WA), potently inhibits NFkappaB activation by preventing the tumor necrosis factor-induced activation of IkappaB kinase beta via a thioalkylation-sensitive redox mechanism, whereas other WS-derived steroidal lactones, such as withanolide A and 12-deoxywithastramonolide, are far less effective. To our knowledge, this is the first communication of IkappaB kinase beta inhibition by a plant-derived inhibitor, coinciding with MEK1/ERK-dependent Ser-181 hyperphosphorylation. This prevents IkappaB phosphorylation and degradation, which subsequently blocks NFkappaB translocation, NFkappaB/DNA binding, and gene transcription. Taken together, our results indicate that pure WA or WA-enriched WS extracts can be considered as a novel class of NFkappaB inhibitors, which hold promise as novel anti-inflammatory agents for treatment of various inflammatory disorders and/or cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
The IKK NF-κB system: a treasure trove for drug development
Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation
Delhase, M., Hayakawa, M., Chen, Y., & Karin, M. (1999) · Science · doi:10.1126/science.284.5412.309 · Cited by 852
Vermeulen, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg139 · Cited by 760
Chen, F., Castranova, V., Shi, X., & Demers, L. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.1.7 · Cited by 718
Vanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M. L., Fiers, W., & Haegeman, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3285 · Cited by 679
Self-citationHostile takeovers: viral appropriation of the NF-kB pathway
Hiscott, J., Kwon, H., & Génin, P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11918 · Cited by 613
Chi, H., Barry, S. P., Roth, R. J., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 569
Screening of some Palestinian medicinal plants for antibacterial activity
Essawi, T., & Srour, M. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(99)00187-7 · Cited by 502
Self-citationLyß, G., Knorre, A., Schmidt, T. J., Pahl, H. L., & Merfort, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33508 · Cited by 474
Zandi, E., Chen, Y., & Karin, M. (1998) · Science · doi:10.1126/science.281.5381.1360 · Cited by 454
Reynaert, N. L., van der Vliet, A., Guala, A. S., McGovern, T., Hristova, M., Pantano, C., Heintz, N. H., Heim, J., Ho, Y.-S., Matthews, D. E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603290103 · Cited by 442
The essential role of MEKK3 in TNF-induced NF-κB activation
Yang, J., Lin, Y., Guo, Z., Cheng, J., Huang, J., Deng, L., Liao, W., Chen, Z., Liu, Z.-G., & Su, B. (2001) · Nature Immunology · doi:10.1038/89769 · Cited by 396
Barnes, P. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00159-8 · Cited by 395
Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · PubMed · Cited by 386
MEKK1 activates both IκB kinase α and IκB kinase β
Lee, F. S., Peters, R. T., Dang, L. C., & Maniatis, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9319 · Cited by 384
Withaferin A is a potent inhibitor of angiogenesis
Mohan, R., Hammers, H., Bargagna-mohan, P., Zhan, X., Herbstritt, C., Ruiz, A., Zhang, L., Hanson, A., Conner, B., Rougas, J., et al. (2004) · Angiogenesis · doi:10.1007/s10456-004-1026-3 · Cited by 382
De Bosscher, K., Schmitz, M. L., Vanden Berghe, W., Plaisance, S., Fiers, W., & Haegeman, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13504 · Cited by 363
Self-citationHehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5617 · Cited by 355
Berghe, W. V., De Bosscher, K., Boone, E., Plaisance, S., & Haegeman, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32091 · Cited by 354
Self-citationEssential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses
Salojin, K. V., Owusu, I. B., Millerchip, K. A., Potter, M., Platt, K. A., & Oravecz, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1899 · Cited by 337
Antifungal activity of plant extracts against dermatophytes
Ali‐Shtayeh, M. S., & Abu Ghdeib, S. I. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00499.x · Cited by 326
Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves
Jayaprakasam, B., Zhang, Y., Seeram, N. P., & Nair, M. G. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.07.007 · Cited by 325
Sandur, S. K., Ichikawa, H., Sethi, G., Ahn, K. S., & Aggarwal, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601595200 · Cited by 322
Antimicrobial activity of 20 plants used in folkloric medicine in the Palestinian area
Ali-Shtayeh, M. S., Yaghmour, R. M.-R., Faidi, Y. R., Salem, K., & Al-Nuri, M. A. (1998) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(97)00153-0 · Cited by 292
Aggarwal, B. B., Ichikawa, H., Garodia, P., Weerasinghe, P., Sethi, G., Bhatt, I. D., Pandey, M. K., Shishodia, S., & Nair, M. G. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.87 · Cited by 286
Kishore, N., Sommers, C., Mathialagan, S., Guzova, J., Yao, M., Hauser, S., Huynh, K., Bonar, S., Mielke, C., Albee, L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211439200 · Cited by 272
NF-κB: tumor promoter or suppressor?
Perkins, N. D. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.004 · Cited by 261
A fully dissociated compound of plant origin for inflammatory gene repression
De Bosscher, K., Berghe, W. V., Beck, I. M. E., Van Molle, W., Hennuyer, N., Hapgood, J., Libert, C., Staels, B., Louw, A., & Haegeman, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505554102 · Cited by 260
Self-citationA20 inhibits NF-κB activation by dual ubiquitin-editing functions
Heyninck, K., & Beyaert, R. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.001 · Cited by 252
Hsp70 promotes TNF-mediated apoptosis by binding IKKγ and impairing NF-κB survival signaling
Ran, R., Lu, A., Zhang, L., Tang, Y., Zhu, H., Xu, H., Feng, Y., Han, C., Zhou, G., Rigby, A. C., et al. (2004) · Genes & Development · doi:10.1101/gad.1188204 · Cited by 242
Ethnobotanical knowledge of local Arab practitioners in the Middle Eastern region
Azaizeh, H., Fulder, S., Khalil, K., & Said, O. (2003) · Fitoterapia · doi:10.1016/s0367-326x(02)00285-x · Cited by 233
Antistressor effect of Withania somnifera
Archana, R., & Namasivayam, A. (1998) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00107-x · Cited by 213
Isoflavone Genistein: Photoprotection and Clinical Implications in Dermatology
Wei, H., Saladi, R., Lu, Y., Wang, Y., Palep, S. R., Moore, J., Phelps, R., Shyong, E., & Lebwohl, M. G. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3811s · Cited by 203
Dissection of the NF-κB signalling cascade in transgenic and knockout mice
Pasparakis, M., Luedde, T., & Schmidt-Supprian, M. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401870 · Cited by 172
Takada, Y., Kobayashi, Y., & Aggarwal, B. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500077200 · Cited by 172
Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides
Schirmer, A., Kennedy, J., Murli, S., Reid, R., & Santi, D. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600445103 · Cited by 169
Amit, S., & Ben‐Neriah, Y. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00096-2 · Cited by 160
Derudder, E., Dejardin, E., Pritchard, L. L., Green, D. R., Körner, M., & Baud, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300106200 · Cited by 160
Takada, Y., Andreeff, M., & Aggarwal, B. B. (2005) · Blood · doi:10.1182/blood-2004-12-4589 · Cited by 143
Enhanced Dephosphorylation of cAMP-dependent Protein Kinase by Oxidation and Thiol Modification
Humphries, K. M., Deal, M. S., & Taylor, S. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410242200 · Cited by 139
Plaisance, S., Berghe, W. V., Boone, E., Fiers, W., & Haegeman, G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3733 · Cited by 139
Self-citationIκB Kinase Is an Essential Component of the Tpl2 Signaling Pathway
Waterfield, M. R., Jin, W., Reiley, W. W., Zhang, M., & Sun, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.6040-6048.2004 · Cited by 134
Adams, D. G., Coffee, R. L., Zhang, H., Pelech, S., Strack, S., & Wadzinski, B. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502464200 · Cited by 133
Panta, G. R., Kaur, S., Cavin, L. G., Cortés, M. L., Mercurio, F., Lothstein, L., Sweatman, T. W., Israel, M., & Arsura, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.1823-1835.2004 · Cited by 131
Loss of the VHR dual-specific phosphatase causescell-cycle arrest and senescence
Rahmouni, S., Cerignoli, F., Alonso, A., Tsutji, T., Henkens, R., Zhu, C., Louis-Dit-Sully, C., Moutschen, M. P., Jiang, W. B., & Mustelin, T. (2006) · Nature Cell Biology · doi:10.1038/ncb1398 · Cited by 126
Berghe, W. V., Francesconi, E., Bosscher, K. D., Resche-Rigon, M., & Haegeman, G. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12543-6 · Cited by 124
Self-citationTakada, Y., Gillenwater, A. M., Ichikawa, H., & Aggarwal, B. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507213200 · Cited by 120
Na, H., & Surh, Y. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20225 · Cited by 116
Constituents of Withania somnifera Dun—XIII
Glotter, E., Kirson, I., Abraham, A., & Lavie, D. (1973) · Tetrahedron · doi:10.1016/s0040-4020(01)83156-2 · Cited by 116
Redox Regulation of MAP Kinase Phosphatase 3
Seth, D., & Rudolph, J. (2006) · Biochemistry · doi:10.1021/bi060157p · Cited by 111
Berghe, W. V., Francesconi, E., Bosscher, K. D., Resche-Rigon, M., & Haegeman, G. (1999) · PubMed · Cited by 108
Self-citationEffect of Withania somnifera on DMBA induced carcinogenesis
Davis, L., & Kuttan, G. (2001) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(00)00404-9 · Cited by 100
Fu, D.-X., Kuo, Y.-L., Liu, B.-Y., Jeang, K.-T., & Giam, C.-Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210631200 · Cited by 95
Liang, M., Bardhan, S., Pace, E. A., Rosman, D. S., Beutler, J. A., Porco, J. A. J., & Gilmore, T. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.013 · Cited by 87
Prajapati, S., Verma, U. N., Yamamoto, Y., Kwak, Y. T., & Gaynor, R. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306273200 · Cited by 83
Maeng, Y., Min, J., Kim, J. H., Yamagishi, A., Mochizuki, N., Kwon, J., Park, Y. W., Kim, Y., & Kwon, Y. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.007 · Cited by 81
Positive Regulation of IκB Kinase Signaling by Protein Serine/Threonine Phosphatase 2A
Kray, A. E., Carter, R. S., Pennington, K. N., Gomez, R. J., Sanders, L. E., Llanes, J. M., Khan, W. N., Ballard, D. W., & Wadzinski, B. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506093200 · Cited by 77
Berghe, W. V., Dijsselbloem, N., Vermeulen, L., Ndlovu, M. N., Boone, E., & Haegeman, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2957 · Cited by 76
Self-citationThe Carboxyl-Terminal Region of IκB Kinase γ (IKKγ) Is Required for Full IKK Activation
Makris, C., Roberts, J. L., & Karin, M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6573-6581.2002 · Cited by 74
Development of withaferin A analogs as probes of angiogenesis
Yokota, Y., Bargagna‐Mohan, P., Ravindranath, P. P., Kim, K. B., & Mohan, R. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.02.039 · Cited by 68
Identification and H2O2 sensitivity of the major constitutive MAPK phosphatase from rat brain
Foley, T. D., Armstrong, J. J., & Kupchak, B. R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.096 · Cited by 56
Fuska, J., Fusková, A., Rosazza, J. P. N., et al. (1984) · PubMed · Cited by 51
4‐Isoavenaciolide covalently binds and inhibits VHR, a dual‐specificity phosphatase
Ueda, K., Usui, T., Nakayama, H., Ueki, M., Takio, K., Ubukata, M., & Osada, H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03065-x · Cited by 47
Binding of Manumycin A Inhibits IκB Kinase β Activity
Bernier, M., Kwon, Y.-K., Pandey, S., Zhu, T., Zhao, R., Maciuk, A., He, H., de Cabo, R., & Kole, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511878200 · Cited by 46
Liang, M., Bardhan, S., Li, C., Pace, E. A., Porco, J. A. J., & Gilmore, T. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.123 · Cited by 46
MKP-8, a novel MAPK phosphatase that inhibits p38 kinase
Vasudevan, S. A., Skoko, J., Wang, K., Burlingame, S. M., Patel, P. N., Lazo, J. S., Nuchtern, J. G., & Yang, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.028 · Cited by 45
Hertlein, E. K., Wang, J., Ladner, K. J., Bakkar, N., & Guttridge, D. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4956-4968.2005 · Cited by 34
Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties
Peyregne, V. P., Kar, S., Ham, S. W., Wang, M., Wang, Z., & Carr, B. I. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0274 · Cited by 33
Suppression of interleukin-6 production in macrophages by furonaphthoquinone NFD-37
Shin, H.-M., Lee, Y. R., Chang, Y. S., Lee, J., Kim, B. H., Min, K. R., & Kim, Y. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.01.006 · Cited by 22
Cited by
Mathews Griner, L. A., Guha, R., Shinn, P., Young, R. M., Keller, J. M., Liu, D., Goldlust, I. S., Yasgar, A., McKnight, C., Boxer, M. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311846111 · Cited by 377
Pharmacologic overview of Withania somnifera, the Indian Ginseng
Dar, N. J., Hamid, A., & Ahmad, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2012-1 · Cited by 370
Natural withanolides: an overview
Chen, L.-X., He, H., & Qiu, F. (2011) · Natural Product Reports · doi:10.1039/c0np00045k · Cited by 358
Withaferin A targets heat shock protein 90 in pancreatic cancer cells
Yu, Y., Hamza, A., Zhang, T., Gu, M., Zou, P., Newman, B., Li, Y., Gunatilaka, A. A. L., Zhan, C.-G., & Sun, D. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.017 · Cited by 316
Paul, S., Chakraborty, S., Anand, U., Dey, S., Nandy, S., Ghorai, M., Saha, S. C., Patil, M. T., Kandimalla, R., Proćków, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112175 · Cited by 306
Metadata
- Authors
- Kaileh, M., Vanden Berghe, W., Heyerick, A., Horion, J., Piette, J., Libert, C., De Keukeleire, D., Essawi, T., & Haegeman, G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 282
- Issue
- 7
- Pages
- 4253-4264
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1993646281
- Cited by
- 301
- References
- 78
- FWCI
- 32.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.